HemoSense

HemoSense develops, manufactures and sells easy-to-use, handheld blood coagulation monitoring systems for use by patients and healthcare professionals in the management of warfarin medication. Our product, the INRatio System, measures the patient’s blood clotting time to ensure that patients with a propensity to form clots are maintained within the therapeutic range with the proper dosage of oral anticoagulant therapy. The INRatio System is 510(k) cleared by the FDA for use by healthcare professionals as well as for patient self-testing, and is also CE marked in Europe. The INRatio System is targeted to both the professional, or point-of-care, market as well as the patient self-testing market, the latter being an opportunity that has emerged primarily following the establishment of Medicare reimbursement in 2002 for mechanical heart valve patients. Several European countries have also implemented national reimbursement coverage of home PT/INR testing for chronic warfarin patients, including Germany, the United Kingdom, Denmark and the Netherlands.

Contact Details: 651 River Oaks Parkway San Jose CA 95134 United States of America Tel: (877)436-6444 or (408)719-1393 Fax: (408)719-1184 Email: moreinfo@hemosense.com WWW: www.hemosense.com/

Loading...

Press Releases on HemoSense:
Reportlinker Adds Anticoagulants - A Global Market Review	18th November, 2009	Reportlinker	NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Anticoagulants - A Global Market Review http://www.reportlinker.com
Reportlinker Adds Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads	5th November, 2009	Reportlinker	NEW YORK, Nov. 5 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.	16th December, 2008	Accumetrics, Inc.	SAN DIEGO, Dec. 16 /PRNewswire/ -- Accumetrics, Inc. has appointed 20-year industry veteran Ad de Waard as Vice President of International Sales and Marketing. "Ad joins us at an important
Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D	4th November, 2008	Accumetrics, Inc.	SAN DIEGO, Nov. 4 /PRNewswire/ -- Accumetrics, Inc. announces the appointment of William H. Dippel to the position of Executive Vice President of Operations and R&D. Mr. Dippel will oversee

HemoSense Clinical Trials:
Patient International Normalised Ratio (INR) Self-Testing Program

HemoSense Patents:
US Patent No.	Title
6673622	Coagulation or lysis assays by measuring impedance
6066504	Coagulation or lysis assays using an electroactive species
6060323	Method and device for measuring blood coagulation or lysis by viscosity changes
6046051	Method and device for measuring blood coagulation or lysis by viscosity changes

HemoSense (HEM) Financial information Links from Barchart
HEM Quote from from Barchart.com
HEM Chart from from Barchart.com
HEM Profile from from Barchart.com
HEM Opinion from from Barchart.com
→View more HemoSense finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1101 times since April 2007, the link to the organisation's website has been followed 192 times

Recent Search Terms used to find this page: pt/inr reimbursement explained 2009 | hemosense | hemosense | hemosense | hemosense inratio patent | patent blood coagulation measurement impedance | HEMOSENSE | Hemosense | Hemosense | william dippel email hemosense | .

Search for more companies in San Jose

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for HemoSense